VOYA Investment Management’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.61M Buy
150,593
+25,192
+20% +$436K ﹤0.01% 1188
2025
Q1
$2.74M Buy
125,401
+2,250
+2% +$49.2K ﹤0.01% 1177
2024
Q4
$3.93M Buy
123,151
+35,185
+40% +$1.12M ﹤0.01% 1057
2024
Q3
$2.54M Sell
87,966
-35,650
-29% -$1.03M ﹤0.01% 1261
2024
Q2
$4.74M Sell
123,616
-371,076
-75% -$14.2M ﹤0.01% 1023
2024
Q1
$29.1M Buy
494,692
+238,159
+93% +$14M 0.03% 449
2023
Q4
$15.4M Buy
256,533
+174,366
+212% +$10.4M 0.02% 601
2023
Q3
$3.13M Sell
82,167
-139,247
-63% -$5.3M ﹤0.01% 1158
2023
Q2
$20.2M Sell
221,414
-57,772
-21% -$5.26M 0.02% 514
2023
Q1
$18.4M Buy
279,186
+113,880
+69% +$7.51M 0.02% 548
2022
Q4
$8.55M Sell
165,306
-7,375
-4% -$381K 0.01% 771
2022
Q3
$11.8M Buy
172,681
+52,109
+43% +$3.56M 0.01% 651
2022
Q2
$5.45M Buy
120,572
+24,563
+26% +$1.11M 0.01% 707
2022
Q1
$4.88M Sell
96,009
-7,867
-8% -$400K 0.01% 846
2021
Q4
$4.91M Buy
103,876
+78,732
+313% +$3.72M 0.01% 848
2021
Q3
$829K Sell
25,144
-337
-1% -$11.1K ﹤0.01% 1708
2021
Q2
$1.61M Sell
25,481
-1,078
-4% -$68.1K ﹤0.01% 1319
2021
Q1
$1.14M Buy
26,559
+181
+0.7% +$7.77K ﹤0.01% 1509
2020
Q4
$1.51M Buy
26,378
+2,000
+8% +$114K ﹤0.01% 1281
2020
Q3
$735K Buy
24,378
+3,521
+17% +$106K ﹤0.01% 1449
2020
Q2
$681K Sell
20,857
-7,377
-26% -$241K ﹤0.01% 1457
2020
Q1
$756K Buy
28,234
+4,247
+18% +$114K ﹤0.01% 1366
2019
Q4
$734K Buy
23,987
+5,261
+28% +$161K ﹤0.01% 1643
2019
Q3
$451K Hold
18,726
﹤0.01% 1829
2019
Q2
$475K Buy
18,726
+3,690
+25% +$93.6K ﹤0.01% 1819
2019
Q1
$293K Sell
15,036
-684
-4% -$13.3K ﹤0.01% 2068
2018
Q4
$207K Buy
15,720
+1,621
+11% +$21.3K ﹤0.01% 2207
2018
Q3
$251K Hold
14,099
﹤0.01% 2234
2018
Q2
$310K Buy
+14,099
New +$310K ﹤0.01% 2126